Therapeutic potential of gene editing
Seamless Therapeutics has raised €12M across 1 funding round from 3 investors, most recently a Seed round in Mar 2023. Based in Dresden, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-03-16 | Seed | €12M |
| BMBF GO-Bio,Forbion,Wellington Partners |
| View deal → |
